Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study

Background: Serum gamma-glutamyltransferase has been recognized as the risk factor of cardiovascular and metabolic diseases. However, the association between serum gamma-glutamyltransferase and the risk of chronic kidney disease is not well known, and no prospective studies have examined separately...

Full description

Bibliographic Details
Main Authors: Mikiko Shibata, Kyoko Kogawa Sato, Shinichiro Uehara, Hideo Koh, Keiko Oue, Hiroshi Kambe, Michio Morimoto, Tomoshige Hayashi
Format: Article
Language:English
Published: Japan Epidemiological Association 2020-04-01
Series:Journal of Epidemiology
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/jea/30/4/30_JE20180240/_pdf
_version_ 1819169534731354112
author Mikiko Shibata
Kyoko Kogawa Sato
Shinichiro Uehara
Hideo Koh
Keiko Oue
Hiroshi Kambe
Michio Morimoto
Tomoshige Hayashi
author_facet Mikiko Shibata
Kyoko Kogawa Sato
Shinichiro Uehara
Hideo Koh
Keiko Oue
Hiroshi Kambe
Michio Morimoto
Tomoshige Hayashi
author_sort Mikiko Shibata
collection DOAJ
description Background: Serum gamma-glutamyltransferase has been recognized as the risk factor of cardiovascular and metabolic diseases. However, the association between serum gamma-glutamyltransferase and the risk of chronic kidney disease is not well known, and no prospective studies have examined separately the relationship of serum gamma-glutamyltransferase with the risk of proteinuria versus that of low estimated glomerular filtration rate (eGFR). Methods: We prospectively followed 9,341 Japanese men who did not have low eGFR, proteinuria, or diabetes, and did not take antihypertensive medications at entry for the analysis of proteinuria, and we followed 9,299 men for the analysis of low eGFR. We defined “persistent proteinuria” as proteinuria detected two or more times consecutively and persistently as ≥1+ on urine dipstick at the annual check-up until the end of follow-up. Low eGFR was defined as eGFR <60 mL/min/1.73 m2. Results: During the 11-year observation period, 151 men developed persistent proteinuria and 1,276 men developed low eGFR. In multivariate models, the highest quartile (≥71 IU/L) of serum gamma-glutamyltransferase was independently related to the development of persistent proteinuria (hazard ratio 3.39; 95% confidence interval, 1.92–5.97) compared with the lowest quartile (≤25 IU/L). In joint analysis of alcohol consumption and serum gamma-glutamyltransferase, non-drinkers in the highest tertile (≥58 IU/L) of serum gamma-glutamyltransferase had the highest risk of persistent proteinuria. However, there was no association between serum gamma-glutamyltransferase and low eGFR. Conclusion: In middle-aged Japanese men, elevated serum gamma-glutamyltransferase was independently associated with future persistent proteinuria, but not with low eGFR.
first_indexed 2024-12-22T19:21:02Z
format Article
id doaj.art-ff842533d9cd4ac3ab3ee0b471e92012
institution Directory Open Access Journal
issn 0917-5040
1349-9092
language English
last_indexed 2024-12-22T19:21:02Z
publishDate 2020-04-01
publisher Japan Epidemiological Association
record_format Article
series Journal of Epidemiology
spelling doaj.art-ff842533d9cd4ac3ab3ee0b471e920122022-12-21T18:15:23ZengJapan Epidemiological AssociationJournal of Epidemiology0917-50401349-90922020-04-0130416316910.2188/jea.JE20180240Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare StudyMikiko Shibata0Kyoko Kogawa Sato1Shinichiro Uehara2Hideo Koh3Keiko Oue4Hiroshi Kambe5Michio Morimoto6Tomoshige Hayashi7Preventive Medicine and Environmental Health, Osaka City University Graduate School of Medicine, Osaka, JapanPreventive Medicine and Environmental Health, Osaka City University Graduate School of Medicine, Osaka, JapanPreventive Medicine and Environmental Health, Osaka City University Graduate School of Medicine, Osaka, JapanHematology, Osaka City University Graduate School of Medicine, Osaka, JapanPreventive Medicine and Environmental Health, Osaka City University Graduate School of Medicine, Osaka, JapanKansai Health Administration Center, Nippon Telegraph and Telephone West Corporation, Osaka, JapanKansai Health Administration Center, Nippon Telegraph and Telephone West Corporation, Osaka, JapanPreventive Medicine and Environmental Health, Osaka City University Graduate School of Medicine, Osaka, JapanBackground: Serum gamma-glutamyltransferase has been recognized as the risk factor of cardiovascular and metabolic diseases. However, the association between serum gamma-glutamyltransferase and the risk of chronic kidney disease is not well known, and no prospective studies have examined separately the relationship of serum gamma-glutamyltransferase with the risk of proteinuria versus that of low estimated glomerular filtration rate (eGFR). Methods: We prospectively followed 9,341 Japanese men who did not have low eGFR, proteinuria, or diabetes, and did not take antihypertensive medications at entry for the analysis of proteinuria, and we followed 9,299 men for the analysis of low eGFR. We defined “persistent proteinuria” as proteinuria detected two or more times consecutively and persistently as ≥1+ on urine dipstick at the annual check-up until the end of follow-up. Low eGFR was defined as eGFR <60 mL/min/1.73 m2. Results: During the 11-year observation period, 151 men developed persistent proteinuria and 1,276 men developed low eGFR. In multivariate models, the highest quartile (≥71 IU/L) of serum gamma-glutamyltransferase was independently related to the development of persistent proteinuria (hazard ratio 3.39; 95% confidence interval, 1.92–5.97) compared with the lowest quartile (≤25 IU/L). In joint analysis of alcohol consumption and serum gamma-glutamyltransferase, non-drinkers in the highest tertile (≥58 IU/L) of serum gamma-glutamyltransferase had the highest risk of persistent proteinuria. However, there was no association between serum gamma-glutamyltransferase and low eGFR. Conclusion: In middle-aged Japanese men, elevated serum gamma-glutamyltransferase was independently associated with future persistent proteinuria, but not with low eGFR.https://www.jstage.jst.go.jp/article/jea/30/4/30_JE20180240/_pdfgamma-glutamyltransferaseproteinuriachronic kidney diseaseprospective cohort studyepidemiology
spellingShingle Mikiko Shibata
Kyoko Kogawa Sato
Shinichiro Uehara
Hideo Koh
Keiko Oue
Hiroshi Kambe
Michio Morimoto
Tomoshige Hayashi
Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study
Journal of Epidemiology
gamma-glutamyltransferase
proteinuria
chronic kidney disease
prospective cohort study
epidemiology
title Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study
title_full Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study
title_fullStr Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study
title_full_unstemmed Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study
title_short Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study
title_sort serum gamma glutamyltransferase daily alcohol consumption and the risk of chronic kidney disease the kansai healthcare study
topic gamma-glutamyltransferase
proteinuria
chronic kidney disease
prospective cohort study
epidemiology
url https://www.jstage.jst.go.jp/article/jea/30/4/30_JE20180240/_pdf
work_keys_str_mv AT mikikoshibata serumgammaglutamyltransferasedailyalcoholconsumptionandtheriskofchronickidneydiseasethekansaihealthcarestudy
AT kyokokogawasato serumgammaglutamyltransferasedailyalcoholconsumptionandtheriskofchronickidneydiseasethekansaihealthcarestudy
AT shinichirouehara serumgammaglutamyltransferasedailyalcoholconsumptionandtheriskofchronickidneydiseasethekansaihealthcarestudy
AT hideokoh serumgammaglutamyltransferasedailyalcoholconsumptionandtheriskofchronickidneydiseasethekansaihealthcarestudy
AT keikooue serumgammaglutamyltransferasedailyalcoholconsumptionandtheriskofchronickidneydiseasethekansaihealthcarestudy
AT hiroshikambe serumgammaglutamyltransferasedailyalcoholconsumptionandtheriskofchronickidneydiseasethekansaihealthcarestudy
AT michiomorimoto serumgammaglutamyltransferasedailyalcoholconsumptionandtheriskofchronickidneydiseasethekansaihealthcarestudy
AT tomoshigehayashi serumgammaglutamyltransferasedailyalcoholconsumptionandtheriskofchronickidneydiseasethekansaihealthcarestudy